N-Butyrylated hyaluronic acid ameliorates gout and hyperuricemia in animal models.

N-Butyrylated hyaluronic acid ameliorates gout and hyperuricemia in animal models.
复制标题

N-丁酰化透明质酸可改善动物模型中的痛风和高尿酸血症

DOI:
10.1080/13880209.2019.1672755
复制
发表时间:
2019-12
影响因子:
3.8
通讯作者:
Anastassiades T
Anastassiades T
中科院分区:
医学3区
文献类型:
--
作者:
Li L;Wang D;Wang X;Bai R;Wang C;Gao Y;Anastassiades T

文献摘要

参考文献

被引文献

相似文献

摘要背景:透明质酸(HA)在结构骨架、关节润滑、肾功能和细胞信号转导等方面发挥着重要作用。我们先前已经证明,部分N-丁酰化的低分子透明质酸(BHA)在培养的人巨噬细胞中显示出抗炎作用,炎症是由TL-4激动剂或低分子HA本身以剂量依赖的方式诱导的。目的:采用急性痛风性关节炎和高尿酸血症动物模型,观察BHA的抗炎、抗氧化和抗高尿酸血症作用。材料和方法:采用大鼠关节腔内注射尿酸单钠诱导的急性痛风性关节炎模型(n μ10/组),以生理盐水对照组为对照,通过测定关节肿胀和血清炎症细胞因子水平来评价10和50 = g关节注射的抗炎作用。给高尿酸血症Balb/C小鼠腹腔注射奥特拉西钾和酵母膏,观察其抗氧化和抗高尿酸活性。结果:在痛风性关节炎大鼠模型中,高剂量(50 μg)牛血清白蛋白具有较强的抗炎作用,可使关节肿胀度和血清IL-1β、IL-8、γ、MCP-1水平分别降低5.56%、6.55%、15.58%和33.18%。在高尿酸血症小鼠模型中,低剂量的BHA(10 μg)能显著降低血清和肝脏的ROS水平14.87%和8.04%,提高肝脏超氧化物歧化酶水平12.77%,足以提供抗氧化活性。腹腔注射BHA可使高尿酸血症小鼠肝脏XO活性降低19.78%,血尿酸水平降低30.41%,从而抑制尿酸生成。结论:本研究首次证实BHA在体内具有抗炎、抗氧化和抗高尿酸血症的作用,提示BHA在痛风性关节炎和高尿酸血症的治疗中具有潜在的应用价值。
Abstract Context: Hyaluronic acid (HA) plays critical roles in the structural skeleton, joint lubrication, renal function and cell signaling. We previously showed that partially N-butyrylated, low molecular weight, hyaluronic acid (BHA) exhibited an anti-inflammatory effect in cultured human macrophage, where inflammation was induced either by a TL-4 agonist or the low molecular weight HA itself, in dose-dependent fashion. Objectives: To investigate the anti-inflammatory, antioxidative, and antihyperuricemic effects of BHA using animal models of acute gouty arthritis and hyperuricemia. Materials and methods: The anti-inflammatory effect of articular BHA (10 and 50 μg) injections was evaluated by measuring joint swelling and the serum levels of inflammatory cytokines in a model of acute gouty arthritis induced by intra-articular injection of monosodium urate crystals in Wistar rats (n = 10/group), in comparison to the control group with saline injection. Antioxidative and antihyperuricemic activities were investigated using intraperitoneal injections of oteracil potassium and yeast extract hyperuricemic Balb/C mice, which were treated with intraperitoneal injection of BHA at day 6–8 in the model. Results: In the gouty arthritis rat model, BHA at a higher dosage (50 μg) demonstrated a strong anti-inflammatory effect by reducing the degree of articular swelling and the serum levels of IL-1β, IL-8, IFN-γ, and MCP-1 by 5.56%, 6.55%, 15.58% and 33.18%. In the hyperuricemic mouse model, lower dosage BHA (10 μg) was sufficient to provide antioxidative activities by significantly decreasing the ROS levels in both serum and liver by 14.87% and 8.04%, while improving liver SOD by 12.77%. Intraperitoneal injection of BHA suppressed uric acid production through reducing liver XO activity by 19.78% and decreased the serum uric acid level in hyperuricemic mice by 30.41%. Conclusions: This study demonstrated for the first time that BHA exhibits anti-inflammatory, antioxidative and antihyperuricemic effects in vivo, suggesting a potential therapeutic application of BHA in gouty arthritis and hyperuricemia.
DOI: 10.1186/s13075-014-0419-y
发表时间: 2014-08-30
影响因子: 4.9
作者:
Greenhill CJ;Jones GW;Nowell MA;Newton Z;Harvey AK;Moideen AN;Collins FL;Bloom AC;Coll RC;Robertson AA;Cooper MA;Rosas M;Taylor PR;O'Neill LA;Humphreys IR;Williams AS;Jones SA
通讯作者: Jones SA
DOI: 10.1186/ar2659
发表时间: 2009
影响因子: 4.9
作者:
Harrold LR;Andrade SE;Briesacher BA;Raebel MA;Fouayzi H;Yood RA;Ockene IS
通讯作者: Ockene IS
DOI: 10.1186/ar2952
发表时间: 2010
影响因子: 4.9
作者:
Busso N;So A
通讯作者: So A
DOI: 10.1016/j.ab.2005.09.041
发表时间: 2005-12-15
影响因子: 2.9
作者:
Davey, MW;Stals, E;Swennen, RL
通讯作者: Swennen, RL
DOI: 10.1007/s11926-016-0579-7
发表时间: 2016-06-01
影响因子: 5
作者:
Keenan, Robert T.;Schlesinger, Naomi
通讯作者: Schlesinger, Naomi